logo

For the Inventor, By the Inventor

Schlieren, Switzerland

Esbatech, an Alcon Biomedical Research Unit LLC


USPTO Granted Patents = 36

% Expired Patents = 22.2



Forward Citations = 183

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal David M Urech (27 out of 50 patents)

silverMedal Leonardo Borras (16 out of 26 patents)

bronzeMedal Alcide Barberis (8 out of 22 patents)

4.  Adrian Auf Der Maur (8 out of 17 patents)

5.  Stefan Ewert (7 out of 15 patents)

6.  Dominik Escher (6 out of 14 patents)

7.  Tea Gunde (5 out of 27 patents)

8.  Valerie Hulmann-Cottier (5 out of 5 patents)

9.  Peter Lichtlen (5 out of 9 patents)

10.  Kathrin Tissot (3 out of 11 patents)

11.  Robert Gurny (2 out of 21 patents)

12.  Lutz Asmus (2 out of 3 patents)

13.  Michael Möller (2 out of 3 patents)

14.  John P A Grimshaw (2 out of 2 patents)

15.  Esther Furrer (1 out of 1 patent)


Core Competencies:
Immunobinders
Antibody Stability
Sustained-Release Formulations
Humanization
Single Chain Antibodies
CDR Grafting
VEGF Inhibition
TNF Alpha Inhibition
Macromolecule Delivery
B-clones Identification
Functionalized Polypeptides
Intracellular Stability

36 patents:

1. 10221237 - Solubility optimization of immunobinders (2019-03-05),
2. 10125186 - Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same (2018-11-13),
3. 10100111 - Stable and soluble antibodies inhibiting TNF alpha (2018-10-16),
4. 10093726 - Protein sustained-release injectable formulation (2018-10-09),
5. 10087244 - Humanization of rabbit antibodies using a universal antibody framework (2018-10-02),
6. 9938336 - Sequence based engineering and optimization of single chain antibodies (2018-04-10),
7. 9908945 - Sequence based engineering and optimization of single chain antibodies (2018-03-06),
8. 9908940 - Humanized immunobinders of cell-surface antigens (2018-03-06),
9. 9873737 - Stable and soluble antibodies inhibiting VEGF (2018-01-23),
10. 9873736 - Protein sustained-release injectable formulation (2018-01-23),
11. 9803027 - Method for decreasing immunogenicity (2017-10-31),
12. 9683034 - Stable and soluble antibodies inhibiting TNFα (2017-06-20),
13. 9593161 - Humanization of rabbit antibodies using a universal antibody framework (2017-03-14),
14. 9556265 - Solubility optimization of immunobinders (2017-01-31),
15. 9518108 - Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same (2016-12-13),
Company Overview
Esbatech, an Alcon Biomedical Research Unit LLC, is a specialized organization based in Schlieren, Switzerland, focused on advancing biomedical technologies. The company is dedicated to the development and manufacturing of innovative solutions in the field of ophthalmology, particularly in the areas of surgical instruments and diagnostic devices. With a commitment to enhancing patient care, Esbatech leverages cutting-edge research to create products that improve vision health and surgical outcomes, contributing significantly to the medical device landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Esbatech, an Alcon Biomedical Research Unit LLC USPTO Patent Assignee Logo
36 Patents

#2 in Schlieren

#388 in Switzerland

#18,745 in the World

Schlieren, CH
Schlieren, Switzerland

Esbatech, an Alcon Biomedical Research Unit LLC

Forward Citations = 183

16 inventors:

goldMedal David M Urech (27 out of 50 patents)

silverMedal Leonardo Borras (16 out of 26 patents)

bronzeMedal Alcide Barberis (8 out of 22 patents)

4.  Adrian Auf Der Maur (8 out of 17 patents)

5.  Stefan Ewert (7 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Esbatech, an Alcon Biomedical Research Unit LLC. Retrieved from https://idiyas.com/company/esbatech-an-alcon-biomedical-research-unit

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…